Development Level

Tbio 8 | 10,625
Tchem 3 | 1,890
Tclin 1 | 602

IMPC Term

abnormal embryo size 1 | 112
decreased circulating calcium ... 1 | 33
decreased heart weight 1 | 44
decreased monocyte cell number 1 | 28
increased circulating glucose ... 1 | 16
increased exploration in new e... 1 | 56
increased prepulse inhibition 1 | 21
preweaning lethality, complete... 1 | 633

Disease

Cancer 12 | 2,346
diabetes mellitus 8 | 1,663
Atherosclerosis 7 | 275
psoriasis 7 | 6,685
Arthritis 6 | 248
Coronary artery disease 6 | 240
Hypersensitivity reaction type II disease 6 | 235
Hypertension 6 | 287
intraductal papillary-mucinous neoplasm (IPMN) 6 | 3,289
Heart disease 5 | 279
Obesity 5 | 616
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,988
oligodendroglioma 5 | 2,849
ovarian cancer 5 | 8,484
Anemia 4 | 252
Asthma 4 | 349
Diarrhea 4 | 155
Inflammatory bowel disease 4 | 142
Kidney disease 4 | 396
Liver disease 4 | 219
Neurodegenerative disease 4 | 383
Neuropathy 4 | 210
Prostatic Neoplasms 4 | 471
astrocytic glioma 4 | 2,241
cystic fibrosis 4 | 1,665
glioblastoma 4 | 5,572
medulloblastoma, large-cell 4 | 6,234
osteosarcoma 4 | 7,933
pancreatic cancer 4 | 2,300
tuberculosis 4 | 1,557
Adenoma 3 | 165
Allergic hypersensitivity disease 3 | 123
Alzheimer's disease 3 | 644
Amyotrophic Lateral Sclerosis 3 | 431
Cerebrovascular disease 3 | 231
Contact Dermatitis 3 | 80
Dementia 3 | 129
Dermatitis 3 | 107
Duchenne muscular dystrophy 3 | 602
Heart failure 3 | 80
Hepatitis C 3 | 90
Hypertensive disease 3 | 193
Infertility 3 | 163
Lung disease 3 | 132
Metabolic syndrome X 3 | 155
Polycystic Ovary Syndrome 3 | 332
Rheumatoid Arthritis 3 | 1,160
Urticaria 3 | 53
adult high grade glioma 3 | 2,148
gastric carcinoma 3 | 832
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
invasive ductal carcinoma 3 | 2,950
lung cancer 3 | 4,466
lung carcinoma 3 | 2,844
malignant mesothelioma 3 | 3,162
pilocytic astrocytoma 3 | 3,086
primary Sjogren syndrome 3 | 789
primary pancreatic ductal adenocarcinoma 3 | 1,271
sarcoidosis 3 | 358
Acute kidney injury 2 | 65
Blindness 2 | 84
Calcinosis 2 | 62
Cataract 2 | 104
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic Nephropathy 2 | 37
Diabetic Retinopathy 2 | 53
Exanthem 2 | 39
Gastritis 2 | 44
Glaucoma 2 | 134
Hyperparathyroidism 2 | 43
Hypersensitivity 2 | 63
Hypogonadism 2 | 70
Hypothyroidism 2 | 89
Impotence 2 | 45
Leishmaniasis 2 | 49
Liver Cirrhosis 2 | 101
Myocardial Ischemia 2 | 169
Neoplasm Metastasis 2 | 138
Osteonecrosis 2 | 25
Osteoporosis 2 | 257
Pancreatitis 2 | 97
Pelvic inflammatory disease 2 | 21
Peripheral vascular disease 2 | 90
Pneumonia 2 | 133
Proteinuria 2 | 63
Rhinitis 2 | 46
Stomach Neoplasms 2 | 282
Thrombocytopenia 2 | 105
Thyrotoxicosis 2 | 38
Waldenstrons macroglobulinemia 2 | 765
active Crohn's disease 2 | 918
acute quadriplegic myopathy 2 | 1,157
dermatomyositis 2 | 933
esophageal adenocarcinoma 2 | 737
hepatocellular carcinoma 2 | 532
interstitial lung disease 2 | 291
limb girdle muscular dystrophy 2A 2 | 156
pediatric high grade glioma 2 | 2,712
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis and treatment for 3 months 2 | 327

Tissue

Endocrine System 12 | 18,512
Female tissues 12 | 18,647
Nervous System 12 | 18,561
Digestive Tract 11 | 18,473
Liver and Pancreas 11 | 18,136
Urinary Tract 11 | 18,444
Blood and immune system 10 | 17,995
Cardiovascular System 10 | 17,958
Male tissues 10 | 17,969
Skin and soft tissues 10 | 18,115
Respiratory system 9 | 17,484

Target Family

Non-IDG 11 | 11,971
Transcription Factor 1 | 1,400

Grant Application

5P51RR013986-09 12 | 12
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Thymocyte selection-associated high mobility group box protein TOX TOX Tbio Transcription Factor -2.98683 990.5 61
Elastin ELN Tbio Non-IDG -3.32189 2025.2 244
Parathyroid hormone PTH Tbio Non-IDG -4.29465 20357.7 972
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
CD40 ligand CD40LG Tchem Non-IDG -4.55502 36580.5 1095
Thioredoxin TXN Tchem Non-IDG -3.16977 1452.1 459
RNA-binding protein FUS FUS Tbio Non-IDG -3.13188 1454.2 252
60 kDa heat shock protein, mitochondrial HSPD1 Tbio Non-IDG -3.53499 3756.0 1112
Insulin-like growth factor-binding protein 7 IGFBP7 Tbio Non-IDG -2.71350 576.7 280